Abstract
A major role of oxygen-radical-induced cellular injury in the pathophysiology of acute central nervous system (CNS) injuries and in the pathogenesis of the chronic neurodegenerative disorders has been increasingly recognized. While proteins, nucleic acids, and carbohydrates are all susceptible to oxygen radical damage, perhaps the most avid targets of oxygen-radical-induced injury are cell membrane lipids, including cholesterol and, in particular, polyunsaturated fatty acids. The process of lipid damage by oxygen radicals is known as lipid peroxidation (LP). Central nervous tissue provides an especially avid environment for the occurrence of LP reactions. One reason for this is the high content of iron found in many brain regions, which varies in parallel with the regional sensitivity to ex vivo LP (Zaleska and Floyd, 1985). Iron participates in both the initiation and propagation of LP (see section 17.2). Additionally, brain and spinal cord membrane phospholipids contain a higher proportion of polyunsaturated fatty acids, such as linoleic acid (18:2) and arachidonic acid (20:4), that are sensitive to LP (White, 1973) in comparison to other tissues.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Althaus, J. S., Andrus, P. K., Williams, C. M., VonVoigtlander, P. F., Cazers, A. R., and Hall, E. D., 1993, The use of salicylate hydroxylation to detect hydroxyl radical generation in ischemic and traumatic brain injury: Reversal by tirilazad mesylate (U-74006F), Molec. Chem. Neuropath. 20:147–162.
Althaus, J. S., Oien, T. T., Fici, G. J., Scherch, H. M., Sethy, V. H., and VonVoigtlander, P. F., 1994, Structure-activity relationships of peroxynitrite scavengers: An approach to nitric oxide neurotoxicity, Res. Comm. Chem. Path. Pharmacol. 83:243–254.
Andrus, P. K., Reck, T. J., and Hall, E. D., 1995, Neuroprotective efficacy of the novel brain-penetrating antioxidant U-101033E in the gerbil forebrain ischemia model, J. Neurotrauma 12:967.
Araki, N., Greenberg, J. H., Uematsu, D., Sladky, J. T., and Reivich, M., 1992, Effect of superoxide dismutase on intracellular calcium in stroke, J. Cereb. Blood Flow Metab. 12:43–52.
Asano, T., Johshita, H., Koide, T., and Takakura, K., 1984, Amelioration of ischaemic cerebral oedema by a free radical scavenger, AVS:l,2-bis(nicotinamido)-propane. An experimental study using a regional ischaemia model in cats, Neurol. Res. 6:163–168.
Asano, T., Matsui, T., and Takuwa, Y., 1991, Lipid peroxidation, protein kinase C and cerebral vasospasm, Crit. Rev. Neurosurg. 1:361–379.
Audus, K. L., Guillot, F. L., and Braughler, J. M., 1991, Evidence for 21-aminosteroid association with the hydrophobic domains of brain microvessel endothelial cells, Free Rad. Biol. Med. 11:361–371.
Beckman, J. S., 1991, The double-edged role of nitric oxide in brain function and superoxide-mediated injury, J. Devel. Physiol. 15:53–59.
Boisvert, D. P. C., and Schreiber, C., 1992, Interrelationship of excitotoxic and free radical mechanisms, in: Pharmacology of Cerebral Ischemia (J. Krieglstein and H. Oberpichler, eds.), Wassenschaftliche Verlaggesellschaft, Stuttgart, pp. 1–10.
Braughler, J. M., and Hall, E. D., 1989, Central nervous system trauma and stroke: I. Biochemical considerations for oxygen radical formation and lipid peroxidation, Free Rad. Biol. Med. 6:289–301.
Braughler, J. M., and Pregenzer, J. F., 1989, The 21-aminosteroid inhibitors of lipid peroxidation: Reactions with lipid peroxyl and phenoxyl radicals, Free Rad. Biol. Med. 7:125–130.
Braughler, J. M., Pregenzer, J. F., Chase, R. L., Duncan, L. A., Jacobsen, E. J., and McCall, J. M., 1987, Novel 21-aminosteroids as potent inhibitors of iron-dependent lipid peroxidation, J. Biol. Chem. 262:10438–10440.
Clemens, J. A., Ho, P. P. K., and Panetta, J. A., 1991, LY178002 reduces rat brain damage after transient global ischemia, Stroke 22:1048–1052.
Cohen, G., 1986, Monoamine oxidase, hydrogen peroxide and Parkinson’s disease, Adv. Neurol. 45:119–125.
Grammas, P., Liu, G.-J., Wood, K., and Floyd, R. A., 1993, Anoxia/reoxygenation induces hydroxyl free radical formation in brain microvessels, Free Rad. Biol. Med. 14:553–557.
Gurney, M. E., Cutting, F. B., Zhai, P., Doble, A., Taylor, C. P., Andrus, P. K., and Hall, E. D., 1996, Antioxidants and inhibitors of glutamatergic transmission have therapeutic benefit in a transgenic model of familial amyotrophic lateral sclerosis, Ann. Neurol. 39:147–157.
Hall, E. D., 1992, Neuroprotective pharmacology of methylprednisolone: A review, J. Neurosurg. 76:13–22.
Hall, E. D., and Braughler, J. M., 1989, Central nervous system trauma and stroke: II. Physiological and pharmacological evidence for the involvement of oxygen radicals and lipid peroxidation, Free Rad. Biol. Med. 6:303–313.
Hall, E. D., and Braughler, J. M., 1993, Free radicals in CNS injury, in: Molecular and Cellular Approaches to the Treatment of Neurological Diseases (S. G. Waxman, ed.), Raven Press, New York, pp. 81–105.
Hall, E. D., Pazara, K. E., and Braughler, J. M., 1988, The 21-aminosteroid lipid peroxidation inhibitor U-74006F protects against cerebral ischemia in gerbils, Stroke 19:997–1002.
Hall, E. D., Yonkers, P. A., Horan, K. L., and Braughler, J. M., 1989, Correlation between attenuation of posttraumatic spinal cord ischemia and preservation of vitamin E by the 21-aminosteroid U-74006F: Evidence for an in vivo antioxidant action, J. Neurotrauma 6:169–176.
Hall, E. D., Pazara, K. E., Braughler, J. M., Linseman, K. L., and Jacobsen, E. J., 1990, Non-steroidal lazaroid U-78517F in models of focal and global cerebral ischemia, Stroke 21(Suppl III):83–87.
Hall, E. D., Braughler, J. M., Yonkers, P. A., Smith, S. L., Linseman, K. L., Means, E. D., Scherch, H. M., Jacobsen, E. J., and Lahti, R. A., 1991a, U-78517F: A potent inhibitor of lipid peroxidation with activity in experimental brain injury and ischemia, J. Pharmacol. Exp. Ther. 258:688–694.
Hall, E. D., Pazara, K. E., and Braughler, J. M., 1991b, Effects of tirilazad mesylate on post-ischemic brain lipid peroxidation and recovery of extracellular calcium in gerbils, Stroke 22:361–366.
Hall, E. D., Yonkers, P. A., Andrus, P. K., Cox, J. W., and Anderson, D. K., 1992, Biochemistry and pharmacology of lipid antioxidants in acute brain and spinal cord injury, J. Neurotrauma 9(Suppl 2):425–442.
Hall, E. D., Andrus, P. K., and Yonkers, P. A., 1993, Brain hydroxyl radical generation in acute experimental head injury, J. Neurochem. 60:588–594.
Hall, E. D., McCall, J. M., and Means, E. D., 1994, Therapeutic potential of the lazaroids (21-aminosteroids) in CNS trauma, ischemia and subarachnoid hemorrhage, Adv. Pharmacol. 28:221–268.
Hall, E. D., Andrus, P. K., Smith, S. L., Oostveen, J. A., Scherch, H. M., Lutzke, B. S., Raub, T. J., Sawada, G. A., Palmer, J. R., Banitt, L. S., Tustin, J. M., Belonga, K. L., Ayer, D. E., and Bundy, G. L., 1995, Neuroprotective efficacy of microvascularly-localized versus brain-penetrating antioxidants, Acta Neurochir. 66(Suppl.):107–113.
Halliwell, B., and Gutteridge, J. M. C., 1991, Free Radicals in Biology and Medicine, Oxford University Press, New York, pp. 1–543.
Imaizumi, S., Woolworth, V., Fishman, R. A., and Chan, P. H., 1990, Liposome-entrapped superoxide dismutase reduces cerebral infarction in cerebral ischemia in rats, Stroke 21:1312–1317.
Jenner, P., Schapira, A. H. V., and Marsden, C. D., 1992, New insights into the cause of Parkinson’s disease, Neurology 42:2241–2250.
Kassell, N., Haley, E. C., Apperson-Hansen, C., and Alves, W. M., 1996, A randomized double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in Europe/Australia/New Zealand, J. Neurosurg. 84:221–228.
Kukreja, R. C., Kontos, H. A., Hess, M. L., and Ellis, E. F., 1986, PGH synthase and lipoxygenase generate superoxide in the presence of NADH and NADPH, Circ. Res. 59:612–619.
Kumar, K., White, B. C., Krause, G. S., Indrieri, R. J., Evans, A. T., Hoehner, T. J., Garritano, A. M., and Koestner, A., 1988, A quantitative morphological assessment of lidoflazine and deferoxamine therapy in global brain ischemia, Neurol. Res. 10:136–140.
Lin, Y, and Phillis, J. W., 1992, Deoxycoformycin and oxypurinol: Protection against focal ischemic brain injury in the rat, Brain Res. 571:272–280.
MacDonald, R. L., Weir, B. K. A., Runzer, T. D., Grace, M. G. A., and Poznansky, M. J., 1992, Effect of intrathecal superoxide dismutase and catalase on oxyhemoglobin-induced vasospasm in monkeys, Neurosurgery 30:529–539.
Mathews, W. R., Marschke, C. K., Jr., and McKenna, R., 1992, Tirilazad mesylate protects endothelium from damage by reactive oxygen, J. Mol. Cell Cardiology 24(suppl. III):517.
McCay, P. B., 1985, Vitamin E: Interactions with free radicals and ascorbate, Ann. Rev. Nutr. 5:323–340.
McCord, J. M., 1985, Oxygen-derived radicals in postischemic tissue injury, New Engl. J. Med. 312:159–163.
Monyer, H., Hartley, D. M., and Choi, D. W, 1990, 21-Aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures, Neuron 5:121–126.
Oostveen, J. A., Andrus, P. K., and Hall, E. D., 1995a, Attenuation of retrograde degeneration of nigrostriatal dopamine neurons in the gerbil forebrain ischemia model, J. Neurotrauma 12:967.
Oostveen, J. A., Carter, D. B., Dunn, E. J., and Hall, E. D., 1995b, Effects of U-101033E on the expression of amyloid protein precursor, apolipoprotein E, glial fibrillary acidic protein and β-amyloid expression following a bilateral carotid occlusion in the gerbil, Neurosci. Abs. 21:1979.
Pahlmark, K., Folbergrova, J., Smith, M.-L., and Siesjo, B. K., 1993, Effects of dimethylthiourea on selective neuronal vulnerability in forebrain ischemia in rats, Stroke 24:731–737.
Panter, S. S., Braughler, J. M., and Hall, E. D., 1992, Dextran-coupled deferoxamine improves outcome in a murine model of head injury, J. Neurotrauma 9:47–53.
Phillis, J. W., 1989, Oxypurinol attenuates ischemia-induced hippocampal damage in the gerbil, Brain Res. Bull 23:267–470.
Phillis, J. W., and Cao, X., 1994, N-t-butyl-α-phenylnitrone (PBN) attenuates focal cortical injury in the rat, Stroke 25:262.
Phillis, J. W., and Clough-Helfman, C., 1990, Protection from cerebral ischemic injury in gerbils with the spin trap agent N-tert-butyl-alpha nitrone, Neurosci. Letts. 116:315–319.
Prehn, J. H. M., Karkoutly, C., Nuglisch, J., Peruche, B., and Krieglstein, J., 1992, Dihydrolipoate reduces neuronal injury after cerebral ischemia, J. Cereb. Blood Flow Metab. 12:78–87.
Raub, T. J., Barsuhn, C. L., Williams, L. R., Decker, D. E., Sawada, G. A., and Ho, N. F. H., 1993, Use of a biophysical-kinetic model to understand the roles of protein binding and membrane partitioning on passive diffusion of highly lipophilic molecules across cellular barriers, J. Drug Targeting 1:269–286.
Rohn, T. T., Hinds, T. R., and Vincenzi, F. F., 1993, Ion transport ATPases as targets for free radical damage: Protection by an aminosteroid of the Ca2+ pump ATPase and Na+/K+ pump ATPase of human red blood cell membranes, Biochem. Pharmacol. 46:525–534.
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O’Regan, J. P., Deng, H.-X., Rahmani, Z., Krizus, A., McKenna-Yasek, D., Cayabyab, A., Gaston, S. M., Berger, R., Tanzi, R. E., Halperin, J. J., Herzfeldt, B., Van den Bergh, R., Hung, W.-Y., Bird, R., Deng, G., Mulder, D. W., Smyth, C., Laing, N. G., Soriano, E., Pericak-Vance, M. A., Haines, J., Rouleau, G. A., Gusella, J. S., Horvitz, H. R., and Brown, R. H., 1993, Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature 362:59–62.
Rosenthal, R. E., Chanderbhan, R., Marshall, G., and Fiskum, G., 1992, Prevention of post-ischemic brain lipid conjugated diene production and neurological injury by hydroxyl-ethyl starch-conjugated deferoxamine, Free Rad. Biol. Med. 12:29–33.
Sano, K., Asano, T., Tanishima, T., and Sasaki, T, 1980, Lipid peroxidation as a cause of cerebral vasospasm, Neurol. Res. 2:253–272.
Siesjo, B. K., Agardh, C.-D., and Bengtsson, F., 1989, Free radicals and brain damage, Cerebrovasc. Brain Metab. Rev. 1:165–211.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., and Floyd, R. A., 1991, Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer’s disease, Proc. Natl. Acad. Sci. USA 88:10540–10543.
Smith, M. A., Richey, P. L., Taneda, S., Kutty, R. K., Sayre, L. M., Monnier, V M., and Perry, G., 1994, Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer’s disease, Ann. N.Y. Acad. Sci. 738:447–454.
Spina, M. B., and Cohen, G., 1989, Dopamine turnover and glutathione oxidation: Implications for Parkinson’s disease, Proc. Natl. Acad. Sci. USA 86:1398–1400.
Subbarao, K. V., Richardson, J. S., and Ang, L. C., 1990, Autopsy samples of Alzheimer’s cortex show increased peroxidation in vitro, J. Neurochem. 55:342–345.
Traystman, R. J., Kirsch, J. R., and Koehler, R. C., 1991, Oxygen radical mechanisms of brain injury following ischemia and reperfusion, J. Appl. Physiol. 71:1185–1195.
Uyama, O., Shiratsuki, N., Matsuyama, T., Nakanishi, T., Matsumoto, Y., Yamada, T., Narita, M., and Sugita, M., 1990, Protective effects of superoxide dismutase on acute cerebral injury of gerbil brain, Free Rad. Biol. Med. 8:265–268.
Uyama, O., Matsuyama, T., Michishita, H., Nakamura, H., and Sugita, M., 1992, Protective effects of human recombinant superoxide dismutase on transient ischemic injury of CA1 neurons in gerbils, Stroke 23:75–81.
Vollmer, D. G., Hongo, K., Ogawa, H., Tsukahara, T., and Kassell, N. F., 1991, A study of the effectiveness of the iron-chelating agent deferoxamine as vasospasm propylaxis in a rabbit model of subarachnoid hemorrhage, Neurosurgery 28:27–32.
White, D. A., 1973, The phospholipid composition of mammalian tissues, in: Function of Phospholipids (G. B. Ansell, J. N. Hawthorne, and R. M. Dawson, eds.), Elsevier, Amsterdam, pp. 441–482.
Youdim, M. B. H., Ben-Schachar, D., and Riederer, P., 1993, The possible role of iron in the etiopathology of Parkinson’s disease, Movement Disorders 8:1–12.
Zaleska, M. M., and Floyd, R. A., 1985, Regional lipid peroxidation in rat brain in vitro: Possible role of endogenous iron, Neurochem. Res. 10:397–410.
Zhang, J., and Piantodosi, C. A., 1994, Prolonged production of hydroxyl radical in rat hippocampus after brain ischemia-reperfusion is decreased by 21-aminosteroids, Neurosci. Letts. 177:127–130.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hall, E.D. (1997). Antioxidant Therapeutic Strategies in CNS Disorders. In: Connor, J.R. (eds) Metals and Oxidative Damage in Neurological Disorders. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0197-2_17
Download citation
DOI: https://doi.org/10.1007/978-1-4899-0197-2_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-0199-6
Online ISBN: 978-1-4899-0197-2
eBook Packages: Springer Book Archive